APO Research

APO RESEARCH · REPORT

Exportin 1

Selected research

Industry Growth & Trends

Global Exportin 1 Industry Growth and Trends Forecast to 2032

Market perspective

The global Exportin 1 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Exportin 1 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Exportin 1 is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Exportin 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Exportin 1 include Biogen Inc, CanBas Co Ltd, Karyopharm Therapeutics Inc, Oita University Institute of Advanced Medicine Inc, Wigen Biomedicine Technology (Shanghai) Co Ltd and Jiangsu Carephar Pharmaceutical Co Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Exportin 1 market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Exportin 1 market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Exportin 1 market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Exportin 1.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Exportin 1 market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Exportin 1 Market by Company

Biogen Inc

CanBas Co Ltd

Karyopharm Therapeutics Inc

Oita University Institute of Advanced Medicine Inc

Wigen Biomedicine Technology (Shanghai) Co Ltd

Jiangsu Carephar Pharmaceutical Co Ltd

Exportin 1 Segment by Type

Chromosome Region Maintenance 1 Protein Homolog

XPO1

Exportin 1 Segment by Application

Oncology

Central Nervous System

Genetic Disorders

Immunology

Infectious Disease

Exportin 1 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Exportin 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Exportin 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Exportin 1.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Exportin 1 manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Exportin 1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Chromosome Region Maintenance 1 Protein Homolog Table 2. Major Company of XPO1 Table 3. Global Exportin 1 Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Exportin 1 Sales by Type (2021-2026) & (K Units) Table 5. Global Exportin 1 Sales Market Share in Volume by Type (2021-2026) Table 6. Global Exportin 1 Sales by Type (2021-2026) & (US$ Million) Table 7. Global Exportin 1 Sales Market Share in Value by Type (2021-2026) Table 8. Global Exportin 1 Price by Type (2021-2026) & (US$/Unit) Table 9. Global Exportin 1 Sales by Type (2027-2032) & (K Units) Table 10. Global Exportin 1 Sales Market Share in Volume by Type (2027-2032) Table 11. Global Exportin 1 Sales by Type (2027-2032) & (US$ Million) Table 12. Global Exportin 1 Sales Market Share in Value by Type (2027-2032) Table 13. Global Exportin 1 Price by Type (2027-2032) & (US$/Unit) Table 14. North America Exportin 1 Sales by Type (2021-2026) & (K Units) Table 15. North America Exportin 1 Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Exportin 1 Sales by Type (2021-2026) & (K Units) Table 17. Europe Exportin 1 Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Exportin 1 Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Exportin 1 Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Exportin 1 Sales by Type (2021-2026) & (K Units) Table 21. Latin America Exportin 1 Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Exportin 1 Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Exportin 1 Sales by Type (2021-2026) & (US$ Million) Table 24. Exportin 1 Industry Trends Table 25. Exportin 1 Industry Drivers Table 26. Exportin 1 Industry Opportunities and Challenges Table 27. Exportin 1 Industry Restraints Table 28. Global Exportin 1 Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Exportin 1 Revenue Market Share by Company (2021-2026) Table 30. Global Exportin 1 Sales by Company (2021-2026) & (K Units) Table 31. Global Exportin 1 Sales Share by Company (2021-2026) Table 32. Global Exportin 1 Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Exportin 1 Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Exportin 1 Major Company Production Sites and Headquarters Table 35. Global Exportin 1 Company, Product Type & Application Table 36. Global Exportin 1 Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Exportin 1 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Exportin 1 Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Exportin 1 Sales by Region (2021-2026) & (K Units) Table 41. Global Exportin 1 Sales Market Share in Volume by Region (2021-2026) Table 42. Global Exportin 1 Sales by Region (2021-2026) & (US$ Million) Table 43. Global Exportin 1 Sales Market Share in Value by Region (2021-2026) Table 44. Global Exportin 1 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Exportin 1 Sales by Region (2027-2032) & (K Units) Table 46. Global Exportin 1 Sales Market Share in Volume by Region (2027-2032) Table 47. Global Exportin 1 Sales by Region (2027-2032) & (US$ Million) Table 48. Global Exportin 1 Sales Market Share in Value by Region (2027-2032) Table 49. Global Exportin 1 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Exportin 1 Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Exportin 1 Sales by Application (2021-2026) & (K Units) Table 52. Global Exportin 1 Sales Market Share in Volume by Application (2021-2026) Table 53. Global Exportin 1 Sales by Application (2021-2026) & (US$ Million) Table 54. Global Exportin 1 Sales Market Share in Value by Application (2021-2026) Table 55. Global Exportin 1 Price by Application (2021-2026) & (US$/Unit) Table 56. Global Exportin 1 Sales by Application (2027-2032) & (K Units) Table 57. Global Exportin 1 Sales Market Share in Volume by Application (2027-2032) Table 58. Global Exportin 1 Sales by Application (2027-2032) & (US$ Million) Table 59. Global Exportin 1 Sales Market Share in Value by Application (2027-2032) Table 60. Global Exportin 1 Price by Application (2027-2032) & (US$/Unit) Table 61. North America Exportin 1 Sales by Application (2021-2026) & (K Units) Table 62. North America Exportin 1 Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Exportin 1 Sales by Application (2021-2026) & (K Units) Table 64. Europe Exportin 1 Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Exportin 1 Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Exportin 1 Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Exportin 1 Sales by Application (2021-2026) & (K Units) Table 68. Latin America Exportin 1 Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Exportin 1 Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Exportin 1 Sales by Application (2021-2026) & (US$ Million) Table 71. Biogen Inc Company Information Table 72. Biogen Inc Business Overview Table 73. Biogen Inc Exportin 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Biogen Inc Exportin 1 Product Portfolio Table 75. Biogen Inc Recent Development Table 76. CanBas Co Ltd Company Information Table 77. CanBas Co Ltd Business Overview Table 78. CanBas Co Ltd Exportin 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. CanBas Co Ltd Exportin 1 Product Portfolio Table 80. CanBas Co Ltd Recent Development Table 81. Karyopharm Therapeutics Inc Company Information Table 82. Karyopharm Therapeutics Inc Business Overview Table 83. Karyopharm Therapeutics Inc Exportin 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Karyopharm Therapeutics Inc Exportin 1 Product Portfolio Table 85. Karyopharm Therapeutics Inc Recent Development Table 86. Oita University Institute of Advanced Medicine Inc Company Information Table 87. Oita University Institute of Advanced Medicine Inc Business Overview Table 88. Oita University Institute of Advanced Medicine Inc Exportin 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Oita University Institute of Advanced Medicine Inc Exportin 1 Product Portfolio Table 90. Oita University Institute of Advanced Medicine Inc Recent Development Table 91. Wigen Biomedicine Technology (Shanghai) Co Ltd Company Information Table 92. Wigen Biomedicine Technology (Shanghai) Co Ltd Business Overview Table 93. Wigen Biomedicine Technology (Shanghai) Co Ltd Exportin 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Wigen Biomedicine Technology (Shanghai) Co Ltd Exportin 1 Product Portfolio Table 95. Wigen Biomedicine Technology (Shanghai) Co Ltd Recent Development Table 96. Jiangsu Carephar Pharmaceutical Co Ltd Company Information Table 97. Jiangsu Carephar Pharmaceutical Co Ltd Business Overview Table 98. Jiangsu Carephar Pharmaceutical Co Ltd Exportin 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Jiangsu Carephar Pharmaceutical Co Ltd Exportin 1 Product Portfolio Table 100. Jiangsu Carephar Pharmaceutical Co Ltd Recent Development Table 101. North America Exportin 1 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 102. North America Exportin 1 Sales by Country (2021-2026) & (K Units) Table 103. North America Exportin 1 Sales Market Share by Country (2021-2026) Table 104. North America Exportin 1 Sales Forecast by Country (2027-2032) & (K Units) Table 105. North America Exportin 1 Sales Market Share Forecast by Country (2027-2032) Table 106. North America Exportin 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. North America Exportin 1 Market Size by Country (2021-2026) & (US$ Million) Table 108. North America Exportin 1 Market Share by Country (2021-2026) Table 109. North America Exportin 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. North America Exportin 1 Market Share Forecast by Country (2027-2032) Table 111. Europe Exportin 1 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. Europe Exportin 1 Sales by Country (2021-2026) & (K Units) Table 113. Europe Exportin 1 Sales Market Share by Country (2021-2026) Table 114. Europe Exportin 1 Sales Forecast by Country (2027-2032) & (K Units) Table 115. Europe Exportin 1 Sales Market Share Forecast by Country (2027-2032) Table 116. Europe Exportin 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Europe Exportin 1 Market Size by Country (2021-2026) & (US$ Million) Table 118. Europe Exportin 1 Market Share by Country (2021-2026) Table 119. Europe Exportin 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Europe Exportin 1 Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Exportin 1 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Exportin 1 Sales by Country (2021-2026) & (K Units) Table 123. Asia-Pacific Exportin 1 Sales Market Share by Country (2021-2026) Table 124. Asia-Pacific Exportin 1 Sales Forecast by Country (2027-2032) & (K Units) Table 125. Asia-Pacific Exportin 1 Sales Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Exportin 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Exportin 1 Market Size by Country (2021-2026) & (US$ Million) Table 128. Asia-Pacific Exportin 1 Market Share by Country (2021-2026) Table 129. Asia-Pacific Exportin 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Asia-Pacific Exportin 1 Market Share Forecast by Country (2027-2032) Table 131. Latin America Exportin 1 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Latin America Exportin 1 Sales by Country (2021-2026) & (K Units) Table 133. Latin America Exportin 1 Sales Market Share by Country (2021-2026) Table 134. Latin America Exportin 1 Sales Forecast by Country (2027-2032) & (K Units) Table 135. Latin America Exportin 1 Sales Market Share Forecast by Country (2027-2032) Table 136. Latin America Exportin 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Latin America Exportin 1 Market Size by Country (2021-2026) & (US$ Million) Table 138. Latin America Exportin 1 Market Share by Country (2021-2026) Table 139. Latin America Exportin 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Latin America Exportin 1 Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Exportin 1 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Exportin 1 Sales by Country (2021-2026) & (K Units) Table 143. Middle East and Africa Exportin 1 Sales Market Share by Country (2021-2026) Table 144. Middle East and Africa Exportin 1 Sales Forecast by Country (2027-2032) & (K Units) Table 145. Middle East and Africa Exportin 1 Sales Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Exportin 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Exportin 1 Market Size by Country (2021-2026) & (US$ Million) Table 148. Middle East and Africa Exportin 1 Market Share by Country (2021-2026) Table 149. Middle East and Africa Exportin 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Middle East and Africa Exportin 1 Market Share Forecast by Country (2027-2032) Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Exportin 1 Distributors List Table 154. Exportin 1 Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Exportin 1 Image Figure 2. Global Exportin 1 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Exportin 1 Market Size (2021-2032) & (US$ Million) Figure 4. Global Exportin 1 Sales (2021-2032) & (K Units) Figure 5. Chromosome Region Maintenance 1 Protein Homolog Image Figure 6. Global Chromosome Region Maintenance 1 Protein Homolog Sales YoY Growth (2021-2032) & (K Units) Figure 7. XPO1 Image Figure 8. Global XPO1 Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Exportin 1 Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Exportin 1 Market Share by Type 2025 VS 2032 Figure 11. North America Exportin 1 Sales Market Share in Volume by Type in 2025 Figure 12. North America Exportin 1 Sales Market Share in Value by Type in 2025 Figure 13. Europe Exportin 1 Sales Market Share in Volume by Type in 2025 Figure 14. Europe Exportin 1 Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Exportin 1 Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Exportin 1 Sales Market Share in Value by Type in 2025 Figure 17. Latin America Exportin 1 Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Exportin 1 Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Exportin 1 Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Exportin 1 Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Exportin 1 Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Oncology Image Figure 24. Global Oncology Sales YoY Growth (2021-2032) & (K Units) Figure 25. Central Nervous System Image Figure 26. Global Central Nervous System Sales YoY Growth (2021-2032) & (K Units) Figure 27. Genetic Disorders Image Figure 28. Global Genetic Disorders Sales YoY Growth (2021-2032) & (K Units) Figure 29. Immunology Image Figure 30. Global Immunology Sales YoY Growth (2021-2032) & (K Units) Figure 31. Infectious Disease Image Figure 32. Global Infectious Disease Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Exportin 1 Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Exportin 1 Market Share by Application 2025 VS 2032 Figure 35. North America Exportin 1 Sales Market Share in Volume by Application in 2025 Figure 36. North America Exportin 1 Sales Market Share in Value by Application in 2025 Figure 37. Europe Exportin 1 Sales Market Share in Volume by Application in 2025 Figure 38. Europe Exportin 1 Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Exportin 1 Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Exportin 1 Sales Market Share in Value by Application in 2025 Figure 41. Latin America Exportin 1 Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Exportin 1 Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Exportin 1 Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Exportin 1 Sales Market Share in Value by Application in 2025 Figure 45. North America Exportin 1 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Exportin 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Exportin 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Exportin 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Exportin 1 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Exportin 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Exportin 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Exportin 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Exportin 1 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Exportin 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Exportin 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Exportin 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Exportin 1 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Exportin 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Exportin 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Exportin 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Exportin 1 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Exportin 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Exportin 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Exportin 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Exportin 1 Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Exportin 1 Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Chromosome Region Maintenance 1 Protein Homolog
  • XPO1
Applications
  • Oncology
  • Central Nervous System
  • Genetic Disorders
  • Immunology
  • Infectious Disease
Companies covered
  • Biogen Inc
  • CanBas Co Ltd
  • Karyopharm Therapeutics Inc
  • Oita University Institute of Advanced Medicine Inc
  • Wigen Biomedicine Technology (Shanghai) Co Ltd
  • Jiangsu Carephar Pharmaceutical Co Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Exportin 1 Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Exportin 1 Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Exportin 1 Market by Type
  6. 1.3.1 Chromosome Region Maintenance 1 Protein Homolog
  7. 1.3.2 XPO1
  8. 1.4 Global Exportin 1 Market Size by Type
  9. 1.4.1 Global Exportin 1 Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Exportin 1 Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Exportin 1 Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Exportin 1 Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Exportin 1 Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Exportin 1 Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Exportin 1 Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Exportin 1 Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Exportin 1 Industry Trends
  2. 2.2 Exportin 1 Industry Drivers
  3. 2.3 Exportin 1 Industry Opportunities and Challenges
  4. 2.4 Exportin 1 Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Exportin 1 Revenue (2021-2026)
  2. 3.2 Global Top Players by Exportin 1 Sales (2021-2026)
  3. 3.3 Global Top Players by Exportin 1 Price (2021-2026)
  4. 3.4 Global Exportin 1 Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Exportin 1 Major Company Production Sites & Headquarters
  6. 3.6 Global Exportin 1 Company, Product Type & Application
  7. 3.7 Global Exportin 1 Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Exportin 1 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Exportin 1 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Exportin 1 Tier 1, Tier 2, and Tier 3
4 Exportin 1 Regional Status and Outlook
  1. 4.1 Global Exportin 1 Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Exportin 1 Historic Market Size by Region
  3. 4.2.1 Global Exportin 1 Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Exportin 1 Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Exportin 1 Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Exportin 1 Forecasted Market Size by Region
  7. 4.3.1 Global Exportin 1 Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Exportin 1 Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Exportin 1 Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Exportin 1 by Application
  1. 5.1 Exportin 1 Market by Application
  2. 5.1.1 Oncology
  3. 5.1.2 Central Nervous System
  4. 5.1.3 Genetic Disorders
  5. 5.1.4 Immunology
  6. 5.1.5 Infectious Disease
  7. 5.2 Global Exportin 1 Market Size by Application
  8. 5.2.1 Global Exportin 1 Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Exportin 1 Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Exportin 1 Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Exportin 1 Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Exportin 1 Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Exportin 1 Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Exportin 1 Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Exportin 1 Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Biogen Inc
  2. 6.1.1 Biogen Inc Company Information
  3. 6.1.2 Biogen Inc Business Overview
  4. 6.1.3 Biogen Inc Exportin 1 Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Biogen Inc Exportin 1 Product Portfolio
  6. 6.1.5 Biogen Inc Recent Developments
  7. 6.2 CanBas Co Ltd
  8. 6.2.1 CanBas Co Ltd Company Information
  9. 6.2.2 CanBas Co Ltd Business Overview
  10. 6.2.3 CanBas Co Ltd Exportin 1 Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 CanBas Co Ltd Exportin 1 Product Portfolio
  12. 6.2.5 CanBas Co Ltd Recent Developments
  13. 6.3 Karyopharm Therapeutics Inc
  14. 6.3.1 Karyopharm Therapeutics Inc Company Information
  15. 6.3.2 Karyopharm Therapeutics Inc Business Overview
  16. 6.3.3 Karyopharm Therapeutics Inc Exportin 1 Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Karyopharm Therapeutics Inc Exportin 1 Product Portfolio
  18. 6.3.5 Karyopharm Therapeutics Inc Recent Developments
  19. 6.4 Oita University Institute of Advanced Medicine Inc
  20. 6.4.1 Oita University Institute of Advanced Medicine Inc Company Information
  21. 6.4.2 Oita University Institute of Advanced Medicine Inc Business Overview
  22. 6.4.3 Oita University Institute of Advanced Medicine Inc Exportin 1 Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Oita University Institute of Advanced Medicine Inc Exportin 1 Product Portfolio
  24. 6.4.5 Oita University Institute of Advanced Medicine Inc Recent Developments
  25. 6.5 Wigen Biomedicine Technology (Shanghai) Co Ltd
  26. 6.5.1 Wigen Biomedicine Technology (Shanghai) Co Ltd Company Information
  27. 6.5.2 Wigen Biomedicine Technology (Shanghai) Co Ltd Business Overview
  28. 6.5.3 Wigen Biomedicine Technology (Shanghai) Co Ltd Exportin 1 Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Wigen Biomedicine Technology (Shanghai) Co Ltd Exportin 1 Product Portfolio
  30. 6.5.5 Wigen Biomedicine Technology (Shanghai) Co Ltd Recent Developments
  31. 6.6 Jiangsu Carephar Pharmaceutical Co Ltd
  32. 6.6.1 Jiangsu Carephar Pharmaceutical Co Ltd Company Information
  33. 6.6.2 Jiangsu Carephar Pharmaceutical Co Ltd Business Overview
  34. 6.6.3 Jiangsu Carephar Pharmaceutical Co Ltd Exportin 1 Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Jiangsu Carephar Pharmaceutical Co Ltd Exportin 1 Product Portfolio
  36. 6.6.5 Jiangsu Carephar Pharmaceutical Co Ltd Recent Developments
7 North America by Country
  1. 7.1 North America Exportin 1 Sales by Country
  2. 7.1.1 North America Exportin 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Exportin 1 Sales by Country (2021-2026)
  4. 7.1.3 North America Exportin 1 Sales Forecast by Country (2027-2032)
  5. 7.2 North America Exportin 1 Market Size by Country
  6. 7.2.1 North America Exportin 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Exportin 1 Market Size by Country (2021-2026)
  8. 7.2.3 North America Exportin 1 Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Exportin 1 Sales by Country
  2. 8.1.1 Europe Exportin 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Exportin 1 Sales by Country (2021-2026)
  4. 8.1.3 Europe Exportin 1 Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Exportin 1 Market Size by Country
  6. 8.2.1 Europe Exportin 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Exportin 1 Market Size by Country (2021-2026)
  8. 8.2.3 Europe Exportin 1 Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Exportin 1 Sales by Country
  2. 9.1.1 Asia-Pacific Exportin 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Exportin 1 Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Exportin 1 Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Exportin 1 Market Size by Country
  6. 9.2.1 Asia-Pacific Exportin 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Exportin 1 Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Exportin 1 Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Exportin 1 Sales by Country
  2. 10.1.1 South America Exportin 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Exportin 1 Sales by Country (2021-2026)
  4. 10.1.3 South America Exportin 1 Sales Forecast by Country (2027-2032)
  5. 10.2 South America Exportin 1 Market Size by Country
  6. 10.2.1 South America Exportin 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Exportin 1 Market Size by Country (2021-2026)
  8. 10.2.3 South America Exportin 1 Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Exportin 1 Sales by Country
  2. 11.1.1 Middle East and Africa Exportin 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Exportin 1 Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Exportin 1 Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Exportin 1 Market Size by Country
  6. 11.2.1 Middle East and Africa Exportin 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Exportin 1 Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Exportin 1 Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Exportin 1 Value Chain Analysis
  2. 12.1.1 Exportin 1 Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Exportin 1 Production Mode & Process
  7. 12.2 Exportin 1 Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Exportin 1 Distributors
  10. 12.2.3 Exportin 1 Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research